Study 1 compared 3 lots of Tdap in adolescents and adults 11–54 years of age; Study 2 compared a group of adolescents 11–13 years of age given Tdap and Hepatitis B (HepB) to a group who received the vaccines 1 month apart; and Study 3 compared Tdap versus Td vaccine given to ...